BioCentury | Oct 6, 2018
Finance

In sight of uncharted territory

...ND ND $243 Amicus Therapeutics Inc. (NASDAQ:FOLD) Celenex 9/10/18 $100 $277 $377 CytoDyn Inc. (Pink:CYDY) ProstaGene LLC...
BioCentury | Apr 25, 2005
Company News

Innovate Oncology, Prostagenics LLC deal

IOVO acquired an exclusive worldwide license to develop and commercialize Prostagenics’ Capridine-Beta for cancer. IOVO is preparing an IND for a Phase I trial of the nitroacridine derivative in prostate cancer, but did not disclose...
Items per page:
1 - 2 of 2
BioCentury | Oct 6, 2018
Finance

In sight of uncharted territory

...ND ND $243 Amicus Therapeutics Inc. (NASDAQ:FOLD) Celenex 9/10/18 $100 $277 $377 CytoDyn Inc. (Pink:CYDY) ProstaGene LLC...
BioCentury | Apr 25, 2005
Company News

Innovate Oncology, Prostagenics LLC deal

IOVO acquired an exclusive worldwide license to develop and commercialize Prostagenics’ Capridine-Beta for cancer. IOVO is preparing an IND for a Phase I trial of the nitroacridine derivative in prostate cancer, but did not disclose...
Items per page:
1 - 2 of 2